ABSTRACT
Oz virus is a novel thogotovirus isolated from ticks that causes lethal infection in mice. We conducted serosurveillance of Oz virus infection among humans and wild mammals in Japan using virus-neutralization tests and ELISAs. Results showed that Oz virus may be naturally infecting humans and other mammalian hosts.
Subject(s)
Thogotovirus , Ticks , Animals , Japan/epidemiology , Mammals , Mice , ZoonosesABSTRACT
To investigate the trends of antimicrobial resistance in pathogens isolated from skin and soft-tissue infections (SSTI) at dermatology departments in Japan, a Japanese surveillance committee conducted the first nationwide survey in 2013. Three main organisms were collected from SSTI at 30 dermatology departments in medical centers and 10 dermatology clinics. A total of 860 strains - 579 of Staphylococcus aureus, 240 of coagulase-negative Staphylococci, and 41 of Streptococcus pyogenes - were collected and shipped to a central laboratory for antimicrobial susceptibility testing. The patient profiles were also studied. Among all 579 strains of S. aureus, 141 (24.4%) were methicillin-resistant (MRSA). Among 97 Staphylococcus epidermidis strains, 54 (55.7%) were methicillin-resistant (MRSE). MRSA and MRSE were more frequently isolated from inpatients than from outpatients. Furthermore, these methicillin-resistant strains were also isolated more frequently from patients with histories of taking antibiotics within 4 weeks and hospitalization within 1 year compared to those without. However, there were no significant differences in MIC values and susceptibility patterns of the MRSA strains between patients with a history of hospitalization within 1 year and those without. Therefore, most of the isolated MRSA cases at dermatology departments are not healthcare-acquired, but community-acquired MRSA. S. pyogenes strains were susceptible to most antibiotics except macrolides. The information in this study is not only important in terms of local public health but will also contribute to an understanding of epidemic clones of pathogens from SSTI.
Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Soft Tissue Infections/microbiology , Staphylococcal Skin Infections/microbiology , Staphylococcus aureus/drug effects , Streptococcal Infections/microbiology , Streptococcus pyogenes/drug effects , Cross-Sectional Studies , Dermatology , Hospitalization/statistics & numerical data , Humans , Japan/epidemiology , Methicillin-Resistant Staphylococcus aureus/drug effects , Microbial Sensitivity Tests , Soft Tissue Infections/epidemiology , Staphylococcal Skin Infections/epidemiology , Streptococcal Infections/epidemiologyABSTRACT
Radiation recall dermatitis (RRD) is an inflammatory reaction limited to previously irradiated areas and occurs following the subsequent administration of a drug. Herein, we present a patient with severe RRD associated with pain and necrosis.
Subject(s)
Breast Neoplasms/radiotherapy , Radiodermatitis/diagnosis , Skin/pathology , Biopsy, Needle , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Middle Aged , Radiodermatitis/etiology , Skin/radiation effectsABSTRACT
Fatty acid binding proteins (FABPs) are capable of binding long-chain FA and are involved in intracellular FA transport and signal transduction. In sebaceous glands, FABP5 is highly expressed in differentiated sebocytes; though, its function remains unclear. In this study, we examined the role of FABP5 in sebocytes using FABP5-deficient mice. The size of sebaceous glands was significantly reduced, while the sebum volume was increased with altered lipid composition in FABP5-deficient mice. However, no significant differences were discerned in the expression of proliferation or differentiation markers including Blimp1, c-myc, Ki67 and peroxisome proliferator-activated receptors (PPAR)γ between wild-type and FABP5-deficient sebaceous glands. The expression of cellular retinoic acid binding protein-2 (CRABP2) that is a competitor of FABP5 for RA signalling was increased in FABP5-deficient mice. These results suggest that FABP5 is involved in the regulation of sebaceous gland activity through modulation of cellular lipid signalling and/or metabolism in the sebocytes.
Subject(s)
Fatty Acid-Binding Proteins/genetics , Lipids/analysis , Neoplasm Proteins/genetics , Sebaceous Glands/metabolism , Sebaceous Glands/pathology , Sebum/chemistry , Animals , Ki-67 Antigen/metabolism , Mice , Peroxisome Proliferator-Activated Receptors/metabolism , Positive Regulatory Domain I-Binding Factor 1 , Proto-Oncogene Proteins c-myc/metabolism , Receptors, Retinoic Acid/metabolism , Sebum/metabolism , Signal Transduction , Transcription Factors/metabolismABSTRACT
Kabuto Mountain virus (KAMV), the new member of the genus Uukuvirus, was isolated from the tick Haemaphysalis flava in 2018 in Japan. To date, there is no information on KAMV infection in human and animals. Therefore, serological surveillance of the infection among humans and wild mammals was conducted by virus-neutralization (VN) test and indirect immunofluorescence assay (IFA). Sera of 24 humans, 59 monkeys, 171 wild boars, 233 Sika deer, 7 bears, and 27 nutria in Yamaguchi Prefecture were analyzed by VN test. The positive ratio of humans, monkeys, wild boars, and Sika deer were 20.8%, 3.4%, 33.9% and 4.7%, respectively. No positive samples were detected in bears and nutria. The correlation coefficients between VN test and IFA in human, monkey, wild boar, and Sika deer sera were 0.5745, 0.7198, 0.9967 and 0.9525, respectively. In addition, KAMV was detected in one pool of Haemaphysalis formosensis ticks in Wakayama Prefecture. These results indicated that KAMV or KAMV-like virus is circulating among many wildlife and ticks, and that this virus incidentally infects humans.
Subject(s)
Bunyaviridae/classification , Ticks , Animals , Bunyaviridae/isolation & purification , Humans , Japan , Phylogeny , Ticks/virologySubject(s)
Arthritis, Psoriatic/genetics , CARD Signaling Adaptor Proteins/genetics , Down Syndrome/genetics , Genetic Predisposition to Disease/genetics , Genetic Variation/genetics , Guanylate Cyclase/genetics , Membrane Proteins/genetics , Adolescent , Age of Onset , Antibodies, Monoclonal/therapeutic use , Arthritis, Psoriatic/diagnosis , Arthritis, Psoriatic/drug therapy , Homozygote , Humans , Infliximab , Male , Treatment OutcomeSubject(s)
Fibroma/pathology , Skin Neoplasms/pathology , Biomarkers, Tumor/analysis , Biopsy , Diagnosis, Differential , Fibroma/chemistry , Fibroma/diagnostic imaging , Fibroma/surgery , Humans , Immunohistochemistry , Male , Middle Aged , Predictive Value of Tests , Skin Neoplasms/chemistry , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/surgery , UltrasonographySubject(s)
Biomarkers, Tumor/analysis , Carcinoma, Verrucous/diagnosis , Diabetic Neuropathies/complications , Skin Neoplasms/diagnosis , Aged , Carcinoma, Verrucous/complications , Humans , Immunohistochemistry , Ki-67 Antigen/analysis , Ki-67 Antigen/biosynthesis , Male , Skin Neoplasms/complications , Tumor Suppressor Protein p53/biosynthesisSubject(s)
Anti-Bacterial Agents/adverse effects , Clindamycin/adverse effects , Drug Eruptions/etiology , Exanthema/chemically induced , Fever/chemically induced , Leukocytosis/chemically induced , Adult , Alanine Transaminase/blood , Anti-Bacterial Agents/administration & dosage , Aspartate Aminotransferases/blood , Betamethasone/therapeutic use , C-Reactive Protein/analysis , Clindamycin/administration & dosage , Drug Eruptions/drug therapy , Exanthema/drug therapy , Female , Fever/drug therapy , Glucocorticoids/therapeutic use , Humans , Immunoglobulin G/blood , Immunoglobulins, Intravenous/therapeutic use , Leukocytosis/drug therapy , SyndromeABSTRACT
We report a case of disto-lateral subungal onychomycosis of the first toe of the right foot of a 33-year-old female. The causative agent was identified as Aspergillus sydowii based on DNA sequencing and the macroscopic and microscopic characteristics of the culture. Initially, the medial one-third of the right first toenail was streaked with numerous yellow longitudinal stripes that had fused, with no symptoms of tinea pedis. Treatment with oral terbinafine and itraconazole was ineffective. Based on this case and on three other cases in the literature, the clinical characteristics of onychomycosis caused by A. sydowii can be summarized as follows: (i) no clinical history of symptoms of tinea pedis; (ii) lack of clinical response to oral antifungal agents; (iii) streaked and turbid appearance of the diseased nail and (iv) presence of dichotomous irregular hyphae, as detected by direct microscopic examination.
Subject(s)
Aspergillus/classification , Aspergillus/isolation & purification , Foot Dermatoses/diagnosis , Onychomycosis/diagnosis , Sequence Analysis, DNA , Adult , Antifungal Agents/administration & dosage , Antifungal Agents/therapeutic use , Aspergillus/genetics , Aspergillus/growth & development , DNA, Fungal/analysis , DNA, Fungal/isolation & purification , Female , Foot Dermatoses/drug therapy , Foot Dermatoses/microbiology , Foot Dermatoses/pathology , Humans , Itraconazole/administration & dosage , Itraconazole/therapeutic use , Microscopy/methods , Naphthalenes/administration & dosage , Naphthalenes/therapeutic use , Onychomycosis/drug therapy , Onychomycosis/microbiology , Onychomycosis/pathology , Phylogeny , Pulse Therapy, Drug , Terbinafine , Treatment FailureABSTRACT
A local epidemiological survey of psoriasis was conducted from 19 February to 30 June 2016 in Matsumoto city, Nagano Prefecture, Japan. Patients were predominantly male (268 cases, 71.5% males vs 107 cases, 28.5% females). We estimated that the prevalence of psoriasis was 0.097% in the Matsumoto area. The clinical types of psoriasis identified were psoriasis vulgaris (90.7%), psoriatic arthritis (5.9%), pustular psoriasis (2.1%), guttate psoriasis (1.0%) and psoriatic erythroderma (0.3%). The topical therapeutic agents included corticosteroids (84.0%), vitamin D3 analogs (61.5%), and a combination of calcipotriol and betamethasone dipropionate (31.0%). Current systemic treatments included cyclosporin (9.0%), etretinate (7.4%) and methotrexate (1.3%). Biologic treatments included adalimumab (4.0%), ustekinumab (2.7%), infliximab (1.3%) and secukinumab (0.8%). Ultraviolet B therapy (11.3%) was the predominant phototherapy in which narrow band ultraviolet B therapy accounted for the majority, followed by psoralen and ultraviolet A therapy (1.0%). According to the recent evolution of psoriasis treatment, the use of biologics has been increasing. This study demonstrates the changes of treatment trends of psoriasis in a non-metropolitan regional area.
Subject(s)
Biological Products/therapeutic use , Health Surveys/statistics & numerical data , Psoriasis/epidemiology , Ultraviolet Therapy/methods , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Humans , Japan , Male , Middle Aged , Prevalence , Psoriasis/therapy , Ultraviolet Therapy/statistics & numerical data , Young AdultABSTRACT
Generalized pustular psoriasis (GPP) is a rare disease characterized by recurrent fever and systemic flushing accompanied by extensive sterile pustules. The committee of the guidelines was founded as a collaborative project between the Japanese Dermatological Association and the Study Group for Rare Intractable Skin Diseases under the Ministry of Health, Labour, and Welfare Research Project on Overcoming Intractable Diseases. The aim of the guidelines was to provide current information to aid in the treatment of patients with GPP in Japan. Its contents include the diagnostic and severity classification criteria for GPP, its pathogenesis, and recommendations for the treatment of GPP. Since there are few clinical trial data with high levels of evidence for this rare disease, recommendations by the committee are described in the present guidelines.
Subject(s)
Dermatologic Agents/therapeutic use , Psoriasis/therapy , Ultraviolet Therapy/standards , Clinical Trials as Topic , Combined Modality Therapy/methods , Combined Modality Therapy/standards , Drug Therapy, Combination/methods , Drug Therapy, Combination/standards , Humans , Japan , Keratolytic Agents/therapeutic use , Psoriasis/diagnosis , Psoriasis/pathology , Severity of Illness Index , Skin/pathology , Treatment Outcome , Ultraviolet Therapy/methodsABSTRACT
We describe a case of purpura fulminans due to septicemia after artificial abortion. Our patient suffered purpuric progressive skin necrosis on the back, extremities and buttock. Rhabdomyolysis involvement was confirmed by high level of creatinine phosphokinase and appearance of much brownish discharge from necrotic gluteal muscle and latissimus dorsi muscle. Amputation of both feet and second, third, fourth and fifth fingers of the right hand was performed. The buttock lesion was reconstructed with the posterolateral thigh V-Y flap after debridement. Other lesions were covered with split-thickness skin grafts.
Subject(s)
Abortion, Induced , Bacteremia/etiology , Disseminated Intravascular Coagulation/etiology , Postoperative Complications , Purpura/etiology , Adult , Bacteremia/microbiology , Buttocks/pathology , Buttocks/surgery , Disseminated Intravascular Coagulation/pathology , Escherichia coli/isolation & purification , Extremities/pathology , Extremities/surgery , Female , Gangrene/etiology , Gangrene/pathology , Gangrene/surgery , Humans , Postoperative Complications/microbiology , Pregnancy , Purpura/pathologyABSTRACT
BACKGROUND: Patients with steroid-resistant bullous pemphigoid (BP) require an appropriate treatment option. OBJECTIVE: A multicenter, randomized, placebo-controlled, double-blind trial was conducted to investigate the therapeutic effect of high-dose intravenous immunoglobulin (IVIG; 400mg/kg/day for 5days) in BP patients who showed no symptomatic improvement with prednisolone (≥0.4mg/kg/day) administered. METHODS: We evaluated the efficacy using the disease activity score on day15 (DAS15) as a primary endpoint, and changes in the DAS over time, the anti-BP180 antibody titer, and safety for a period of 57days as secondary endpoints. RESULTS: We enrolled 56 patients in this study. The DAS15 was 12.5 points lower in the IVIG group than in the placebo group (p=0.089). The mean DAS of the IVIG group was constantly lower than that of the placebo group throughout the course of observation, and a post hoc analysis of covariance revealed a significant difference (p=0.041). Furthermore, when analyzed only in severe cases (DAS≥40), the DAS15 differed significantly (p=0.046). The anti-BP180 antibody titers showed no difference between the two groups. CONCLUSION: IVIG provides a beneficial therapeutic outcome for patients with BP who are resistant to steroid therapy.
Subject(s)
Drug Resistance , Glucocorticoids/pharmacology , Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/therapeutic use , Pemphigoid, Bullous/therapy , Prednisolone/pharmacology , Aged , Aged, 80 and over , Autoantibodies/blood , Autoantigens/immunology , Double-Blind Method , Female , Glucocorticoids/administration & dosage , Glucocorticoids/therapeutic use , Humans , Immunoglobulins, Intravenous/administration & dosage , Immunoglobulins, Intravenous/adverse effects , Immunologic Factors/administration & dosage , Immunologic Factors/adverse effects , Male , Middle Aged , Non-Fibrillar Collagens/immunology , Pemphigoid, Bullous/immunology , Prednisolone/administration & dosage , Prednisolone/therapeutic use , Treatment Outcome , Collagen Type XVIISubject(s)
Cyclooxygenase 2 Inhibitors/adverse effects , Drug Eruptions/etiology , Etodolac/adverse effects , Exanthema/chemically induced , Psoas Abscess/complications , Skin Diseases, Papulosquamous/chemically induced , Skin/drug effects , Acute Disease , Aged , Biopsy , Drug Eruptions/drug therapy , Drug Eruptions/pathology , Exanthema/drug therapy , Exanthema/pathology , Humans , Immunosuppressive Agents/adverse effects , Male , Psoas Abscess/diagnosis , Skin/pathology , Skin Diseases, Papulosquamous/drug therapy , Skin Diseases, Papulosquamous/pathologyABSTRACT
According to a recent classification, self-healing papular mucinosis (SHPM) is a subtype of papular mucinosis (also known as lichen myxedematosus), which is in turn a type of idiopathic localized cutaneous mucinosis. SHPM tends to occur in children, but there have been a few reports of an adult type. We report a 70-year-old Japanese woman who presented with reddish, rice-kernel-sized papules of a few days' duration on her right arm. She had a 25-year history of rheumatoid arthritis, which had been well treated with a low dose of corticosteroid as well as some other medications. No paraproteinemia or thyroid dysfunction were observed. The eruptions spontaneously resolved within 2.5 months of onset. Histological findings showed a well-circumscribed mucinous stroma surrounded by dermal mesenchymal cells, such as fibroblast-like cells in the middle of the dermis. Immunohistochemically, these cells were positive only for vimentin on the mucinous lesion. On the circumference of the mucinous lesion, these cells expressed either CD34 or factor XIIIa (FXIIIa). Because vimentin was common to dermal mesenchymal cells, we defined the cells expressing CD34 or FXIIIa, except for vimentin+ cells lacking CD34 or FXIIIa, as dermal dendritic cells (DDC). The findings of the present case suggest that CD34+ or FXIIIa+ DDC and tryptase-positive mast cells on the perilesional area in combination with vimentin+ cells on the mucinous lesion might have given rise to the dermal deposition of mucin in our case. These cells, which are possibly activated in an autoimmune manner associated with rheumatoid arthritis, might play important roles in the development of dermal deposition of mucin in SHPM.
Subject(s)
Arthritis, Rheumatoid , Dendritic Cells/metabolism , Mucinoses/diagnosis , Mucins/metabolism , Aged , Antigens, CD34/metabolism , Diagnosis, Differential , Factor XIIIa/metabolism , Female , Humans , Mucinoses/pathology , Remission, SpontaneousABSTRACT
Carotenemia is characterized by an abnormal yellowish orange pigmentation of the skin, most prominently seen on the palms and soles. Although it is associated with several disease such as diabetes, hypothyroidism and anorexia nervosa, it is caused by excessive intake of carotene-rich food such as oranges and carrots in most cases. Herein, we describe an interesting case of carotenemia in a 66-year-old female secondary to increased ingestion of oral supplements of carotene in order to improve hemorrhage in the eyeground. There could be an increasing trend of intake of commercial nutrient supplements in which case it is necessary to remind ourselves that commercial nutrient supplements could cause various skin disorders as side-effects.
Subject(s)
Carotenoids/adverse effects , Dietary Supplements/adverse effects , Pigmentation Disorders/etiology , Aged , Female , Follow-Up Studies , Hand Dermatoses/etiology , Hand Dermatoses/physiopathology , Humans , Pigmentation Disorders/physiopathology , Risk FactorsABSTRACT
Hepatitis E virus (HEV) is the causative agent of hepatitis E, a food- and water-borne disease. In developed countries, consumption of meats from pigs, wild boars and deer is a major source of infection. Although HEV and HEV-related viruses have been detected in many animal species, their zoonotic potential and prevalence has not been completely understood. To detect anti-HEV antibody in mammalian species, a simple enzyme-linked immunosorbent assay (ELISA) was established using extract from cells expressing HEV capsid protein and protein A/G as an antigen and a reagent for detection of antibody. Absorbance in the ELISA was compared with those in our previous ELISA using VLPs and anti-swine antibody, suggesting that newly established ELISA was similarly specific and sensitive as the previous ELISA. Seroprevalence of HEV infection among wild boars was examined in Yamaguchi Prefecture, confirming that 111 of 364 wild boars (30.5%) were positive for anti-HEV antibody. Next, this ELISA was applied to humans, dogs, cats, ferrets, raccoons and masked palm civets in Japan, and anti-HEV antibodies were detected in humans, ferrets, dogs and cats. This ELISA is thus useful for serological surveys and comparison of HEV infection among various mammals, including humans.